Hemochromatosis Protein

"Hemochromatosis Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A membrane protein and MHC class I antigen. It contains an IMMUNOGLOBULIN C1-SET DOMAIN and interacts with BETA 2-MICROGLOBULIN. It may also regulate the interaction of TRANSFERRIN with the TRANSFERRIN RECEPTOR. Mutations in the HFE gene are associated with cases of FAMILIAL HEMOCHROMATOSIS.

Descriptor ID	D000071020
MeSH Number(s)	D12.776.395.550.489.200 D12.776.543.550.439.200 D23.050.301.500.100.363 D23.050.705.552.100.375
Concept/Terms	Hemochromatosis Protein Hemochromatosis Protein HLA-H Antigen Antigen, HLA-H HLA H Antigen HFE Protein

Below are MeSH descriptors whose meaning is more general than "Hemochromatosis Protein".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Glycoproteins [D12.776.395]
Membrane Glycoproteins [D12.776.395.550]
Histocompatibility Antigens Class I [D12.776.395.550.489]
Hemochromatosis Protein [D12.776.395.550.489.200]
Membrane Proteins [D12.776.543]
Membrane Glycoproteins [D12.776.543.550]
Histocompatibility Antigens Class I [D12.776.543.550.439]
Hemochromatosis Protein [D12.776.543.550.439.200]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Surface [D23.050.301]
Histocompatibility Antigens [D23.050.301.500]
Histocompatibility Antigens Class I [D23.050.301.500.100]
Hemochromatosis Protein [D23.050.301.500.100.363]
Isoantigens [D23.050.705]
Histocompatibility Antigens [D23.050.705.552]
Histocompatibility Antigens Class I [D23.050.705.552.100]
Hemochromatosis Protein [D23.050.705.552.100.375]

Below are MeSH descriptors whose meaning is related to "Hemochromatosis Protein".

Below are MeSH descriptors whose meaning is more specific than "Hemochromatosis Protein".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hemochromatosis Protein" by people in this website by year, and whether "Hemochromatosis Protein" was a major or minor topic of these publications.

Bar chart showing 33 publications over 17 distinct years, with a maximum of 5 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	2	2
1998	0	1	1
1999	0	1	1
2000	0	3	3
2001	0	1	1
2002	0	3	3
2003	0	2	2
2005	0	2	2
2006	0	5	5
2008	0	1	1
2009	0	3	3
2010	0	1	1
2011	0	3	3
2012	0	2	2
2013	0	1	1
2019	1	0	1
2023	0	1	1

Below are the most recent publications written about "Hemochromatosis Protein" by people in Profiles.

Parrow NL, Fleming RE. Transferrin receptor 1: keeper of HFE. Blood. 2023 01 26; 141(4):332-333.

View in: PubMed
Chaudhary K, Chilakala A, Ananth S, Mandala A, Veeranan-Karmegam R, Powell FL, Ganapathy V, Gnana-Prakasam JP. Renal iron accelerates the progression of diabetic nephropathy in the HFE gene knockout mouse model of iron overload. Am J Physiol Renal Physiol. 2019 08 01; 317(2):F512-F517.

View in: PubMed
Galesloot TE, Geurts-Moespot AJ, den Heijer M, Sweep FC, Fleming RE, Kiemeney LA, Vermeulen SH, Swinkels DW. Associations of common variants in HFE and TMPRSS6 with iron parameters are independent of serum hepcidin in a general population: a replication study. J Med Genet. 2013 Sep; 50(9):593-8.

View in: PubMed
Vujic Spasic M, Sparla R, Mleczko-Sanecka K, Migas MC, Breitkopf-Heinlein K, Dooley S, Vaulont S, Fleming RE, Muckenthaler MU. Smad6 and Smad7 are co-regulated with hepcidin in mouse models of iron overload. Biochim Biophys Acta. 2013 Jan; 1832(1):76-84.

View in: PubMed
List AF, Baer MR, Steensma DP, Raza A, Esposito J, Martinez-Lopez N, Paley C, Feigert J, Besa E. Deferasirox reduces serum ferritin and labile plasma iron in RBC transfusion-dependent patients with myelodysplastic syndrome. J Clin Oncol. 2012 Jun 10; 30(17):2134-9.

View in: PubMed
Corradini E, Rozier M, Meynard D, Odhiambo A, Lin HY, Feng Q, Migas MC, Britton RS, Babitt JL, Fleming RE. Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe. Gastroenterology. 2011 Nov; 141(5):1907-14.

View in: PubMed
Castoldi M, Vujic Spasic M, Altamura S, Elm?n J, Lindow M, Kiss J, Stolte J, Sparla R, D'Alessandro LA, Klingm?ller U, Fleming RE, Longerich T, Gr?ne HJ, Benes V, Kauppinen S, Hentze MW, Muckenthaler MU. The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest. 2011 Apr; 121(4):1386-96.

View in: PubMed
Swinkels DW, Fleming RE. Novel observations in hereditary hemochromatosis: potential implications for clinical strategies. Haematologica. 2011 Apr; 96(4):485-8.

View in: PubMed
Gao J, Chen J, De Domenico I, Koeller DM, Harding CO, Fleming RE, Koeberl DD, Enns CA. Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice. Blood. 2010 Apr 22; 115(16):3374-81.

View in: PubMed
Rodriguez A, Luukkaala T, Fleming RE, Britton RS, Bacon BR, Parkkila S. Global transcriptional response to Hfe deficiency and dietary iron overload in mouse liver and duodenum. PLoS One. 2009 Sep 29; 4(9):e7212.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement